Vitalant - Vitalant | Corporate News

Vitalant Statement Regarding FDA’s Proposed Individual Risk Assessment for Blood Donations

Vitalant's statement regarding the FDA’s draft guidance "Recommendations for Evaluating Donor Eligibility Using Individual Risk-Based Questions to Reduce the Risk of HIV Transmission by Blood and Blood Products".

Local Media Inquiries

National Media Inquiries
480-675-5413

Vitalant Media Kit

Give Blood With Vitalant During National Donate Life Month

Apr. 1, 2021 — National Donate Life Month in April honors those who have saved lives through the gift of organ donation. Many organ transplants require blood and platelets to support patients during surgery.

Donate Blood in March to Support Patients with Bleeding Disorders

Mar. 3, 2021 - March is Bleeding Disorders Awareness Month—a great reminder for new and current blood donors to schedule an appointment to support the millions of patients across the U.S. who rely on regular donations for their treatment.

Widespread Snow and Ice Disrupting Nation’s Blood Supply

Feb. 18, 2021 – Severe winter storms bringing debilitating snow, ice and cold to much of the United States are causing widespread concern for the nation’s blood supply.

Give from the Heart; Give Blood with Vitalant in February

Feb. 2, 2021 – One of the benefits of blood donation is the mini-physical every donor receives, including a check of pulse and blood pressure as well as a cholesterol test. February is Heart Health Month, a great time to give blood and get a health check.

Resolve to Give Blood with Vitalant

Jan. 4, 2021 - Vitalant encourages people to help meet the ongoing need for blood, platelets and convalescent plasma by resolving to donate this January—National Blood Donor Month.

Give One Last Gift this Holiday Season with a Blood Donation

Dec. 8, 2020 – Vitalant encourages new and existing donors of all blood types to give one last gift this holiday season by giving blood for patients in need. Giving blood, platelets or plasma continues to be an essential activity as designated by the U.S. Surgeon General and Federal Emergency Management Agency during the COVID-19 pandemic.